Acasti Pharma Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
25.6 M |
Public Float |
9.49 M |
Acasti Pharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.86 |
Market Cap |
$110.91 M |
Shares Outstanding |
25.6 M |
Public Float |
9.49 M |
Address |
545 Promenade du Centropolis Laval Québec H7T 0A3 Canada |
Employees | - |
Website | http://www.acastipharma.com |
Updated | 07/08/2019 |
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada. |